Paul J. Utz
Corporate Officer/Principal chez Nano BioDynamics, Inc.
Profil
Paul J.
Utz is the founder of Bayhill Therapeutics, Inc. founded in 2001.
He is currently the Director-Center for Clinical Immunology at Stanford University, a member of the Advisory Board at Nano BioDynamics, Inc. and Adeptient, Inc., and the Secretary & Treasurer at Federation of Clinical Immunology Societies.
He previously served as a member of the Advisory Board at WaferGen Bio-systems, Inc. Dr. Utz received his doctorate degree from Stanford University in 1991 and his undergraduate degree from King's College (Pennsylvania) in 1986.
Postes actifs de Paul J. Utz
| Sociétés | Poste | Début |
|---|---|---|
| Nano BioDynamics, Inc. | Corporate Officer/Principal | - |
| Adeptient, Inc. | Corporate Officer/Principal | - |
| Stanford University | Corporate Officer/Principal | - |
| Federation of Clinical Immunology Societies | Secrétaire Général | - |
Anciens postes connus de Paul J. Utz
| Sociétés | Poste | Fin |
|---|---|---|
Bayhill Therapeutics, Inc.
 Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Fondateur | 26/12/2013 |
| WAFERGEN BIO-SYSTEMS, INC. | Corporate Officer/Principal | - |
Formation de Paul J. Utz
| Stanford University | Doctorate Degree |
| King's College (Pennsylvania) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Bayhill Therapeutics, Inc.
Bayhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bayhill Therapeutics, Inc. develops and commercializes therapeutics. Its technology is BHT-DNA. The firm is a clinical-stage biopharmaceutical company leveraging its proprietary therapeutic BHT-DNA platform to develop a pipeline of novel and targeted treatment candidates for autoimmune diseases. Bayhill Therapeutics was founded by Lawrence Steinman, Hideki Garren, William H. Robinson and Paul J. Utz in 2001 and is headquartered in Palo Alto, CA. | Health Technology |
WaferGen Bio-systems, Inc.
 WaferGen Bio-systems, Inc. BiotechnologyHealth Technology WaferGen Bio-systems, Inc. used to provide genomic technology solutions for single-cell analysis and clinical research. The firm offered SmartChip Real-Time polymerase chain reaction (PCR) system, which provided a suite of gene expression and genome analysis technologies enabling biomarker discovery and validation on a single platform with the sensitivity and accuracy of PCR. The company was founded by Alnoor Shivji, Victor Joseph and Amjad Huda on October 22, 2002 and was headquartered in Fremont, CA. | Health Technology |
| Nano BioDynamics, Inc. | |
| Adeptient, Inc. | |
| Federation of Clinical Immunology Societies |